True North makes partial exit from drug research firm with strong gains

Premium

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.It sold a 4.5% stake in Mumbai-listed Syngene International Ltd for Rs 427.50 crore ($65.8 million) through a block trade on Thursday, according to ......